A pair of common tests might help colorectal cancer patients who have undergone surgery remain cancer-free, British researchers say. Both a standard CT scan and a blood test known as CEA (carcinoembryonic antigen) improved doctors' ...
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
The molecular cancer diagnostics company, Agendia, has introduced ColoPrint microarray-based 18-gene expression assay. The ColoPrint assay is designed for predicting the risk of distant recurrence for stage II colon cancer patients who ...
Tags: molecular cancer diagnostics, expression assay, cancer diagnostics